INTRODUCTION 71
Blood glucose control is a critical aspect of diabetes care (Jia, 2016) . People with diabetes, or 72 individuals experiencing hyperglycaemia (Godoy et al., 2012 , Farrokhi et al., 2011 may be 73 offered personal care plans (PCPs) (Coulter et al., 2013) to help them manage their blood 74 glucose (Diabetes UK, 2009) . A PCP usually consists of a written document outlining 75 specific goals, and activities designed to achieve these objectives (Diabetes UK, 2009 , 76 Coulter et al., 2013 , The Health Developer Network, 2016 . PCPs reflect a partnership 77 between the doctor/nurse and their patients (Diabetes UK, 2017) , are essential for effective 78 self-management (Jansen et al., 2015 , Tarkin et al., 2008 , and have been implicated in 79 improved patient outcomes (Hird et al., 2015 , Russell et al., 2008 . 80
PCPs are presumed to play an important role in HbA1c (glycated haemoglobin) levels 81 (Diabetes UK, 2009). Setting clear goals for glycaemic control (e.g., achievable HbA1c 82 targets), and designating specific actions to attain these objectives (e.g., weekly participation 83 in a local sports programme), can help patients initiate and sustain key lifestyle changes 84 essential for reducing HbA1c (Coulter et al., 2013) . A recent Cochrane review of the effects of 85 personalised care planning in adults with long-term conditions found HbA1c levels to be 86 0.24% lower in patients with a PCP, compared to those receiving usual care (Coulter et al., 87 renal function, increasing retinopathy, and other complications, in patients with type 1 121 diabetes (Waden et al., 2008) . Evidence from a long-term prospective study of over 11,000 122 patients with type 2 diabetes found that moderate-to-vigorous levels of physical activity (of at 123 least 15 minutes per week) at baseline was associated with a reduced incidence of 124 cardiovascular events, microvascular complications, and mortality rates, over a 5-year period 125 (Blomster et al., 2013) . 126
Despite evidence implicating BMI/physical activity in HbA1c levels (Senechal et al., 127 2013 , Quirk et al., 2014 , and diabetes complications (Blomster et al., 2013 , Waden et al., 128 2008 , Segula, 2014 , it is unclear the extent to which these factors influence the relationship 129 between PCPs and glycaemic control (Diabetes UK, 2017 follows that HbA1c reductions associated with having a PCP will be partly attributable to 134 changes in BMI and/or levels of physical activity. Similarly, poor weight control, and/or 135 failure to adhere to physical activity targets, may negative the influence of PCPs on 136 glycaemic control. 137
Nurses typically form part of health care teams who work in partnership with patients 138 to arrange and monitor PCPs (Coulter et al., 2013) , including information prescriptions 139 (Diabetes UK, 2015b, Diabetes UK, 2017). Guidance published by Diabetes UK makes 140 provision for a health professional to be named on information prescriptions, with a statement 141 specifically inviting patients to discuss and agree achievable HbA1c targets with a doctor or 142 nurse (Diabetes UK, 2015a). There is particular emphasis on controlling HbA1c levels, in 143 order to reduce the risk of complications (Diabetes UK, 2015a). Prescriptions makes specificconversations about BMI/physical activity, in relation to glycaemic control (Diabetes UK, 146 2015a). As both BMI and physical activity contribute significantly to HbA1c, and related 147 complications (Segula, 2014 , Bhupathiraju and Hu, 2016 , Blomster et al., 2013 , it is 148 essential to better understand how these factors influence the relationship between PCPs and 149 HbA1c levels (Diabetes UK, 2015a) . 150
151

AIM 152
This study had two objectives. The first was to establish the association between PCPs and 153 HbA1c levels. Current literature suggests HbA1c can be both a precursor and outcome of 154
PCPs. In the former scenario HbA1c level is used as a criterion for offering PCPs to patients 155 (Diabetes UK, 2015a, Diabetes UK, 2015b). In the latter situation, PCPs can help patients 156 lower their HbA1c level (Coulter et al., 2015) . Both directions of causality are valid. For the 157 purposes of this paper, PCP status (i.e., whether or not a patient has a PCP) was treated as the 158 'predictor' variable, and HbA1c as the 'outcome' measure. This is consistent with a primary 159 objective of personalised care -to improve glycaemic control (Coulter et al., 2015) -but 160 does not preclude the use of HbA1c as a basis for offering PCPs to patients (Diabetes UK, 161 2015a, Diabetes UK, 2017). The second objective was to determine the extent to which BMI 162 and physical activity explain any relationship between PCPs and HbA1c levels. 163
It was expected that (a) patients with PCPs will have lower HbA1c levels compared to 164 patients who had not agreed a care plan, and (b) BMI and physical activity will be implicated 165 in this relationship, as mediating factors, such that the relationship between PCPs and HbA1c 166 is partly explained by BMI and physical activity. Thus, for example, lower HbA1c values in 167 patients with a PCP may partly reflect lower BMI scores, and/or greater physical activity 168 levels in such patients. These hypotheses were tested both prior to and following adjustments 169 for selected covariates, including diabetes status.
METHOD 171
Sample and procedure 173
This study analysed data on PCP status, HbA1c, BMI, and physical activity, obtained from the 174 
Measures 185
Glycated haemoglobin (HbA1c) was based on non-fasting blood samples, and (for this 186 study) calibrated in mmol/mol. HbA1c data provides a measure of average blood glucose 187 levels over the previous three months (Jia, 2016) . 188 PCP status was assessed via two questions. Firstly, respondents were asked if (a) they 189 had ever had a PCP-related discussion with a doctor/nurse regarding a long-term condition, 190 'Yes' (1)/ 'No or not sure' (0); and (b) whether they had agreed a PCP with a health 191 professional during the past 12 months, 'no PCP agreed' (0)/ 'agreed a PCP < or > 12 months 192 ago' (1). Responses to both items were combined to form a PCP index, with a higher 193 indicating a better PCP status (e.g., discussed and/or agreed a PCP).
Physical activity was measured using the short IPAQ (International Physical Activity 195
Questionnaire) (Booth, 2000) . The IPAQ/Short assesses three activity levels -walking, with a health professional, while the remainder (12.3%) had agreed a PCP with a 233 doctor/nurse, ≤ or ≥ 12 months ago. These groups did not differ on measures physical activity 234 (both groups achieved the recommended ≥ 150 minutes of moderate-intensity activity), BMI 235 score (both groups classified as 'Overweight'), mental wellbeing score, or gender 236 distribution. There were also no group differences in the proportion who had been diagnosed 237 with high blood pressure by a doctor/nurse (over 98% of respondents had received this 238 diagnosis), and the proportion receiving earnings from employment or self-employment. 239
However, patients who had agreed a PCP were slightly younger, more likely to have been 240 diagnosed with diabetes, and had higher blood glucose levels (HbA1c). 241 Table 2 shows the bivariate associations between variables. Patients who had 242 discussed and agreed a PCP with their doctor were younger, generated higher HbA1c values, 243 more likely to have been diagnosed with diabetes, and performed fewer minutes of moderateintensity physical activity during the previous 7 days. In addition to denoting diabetes status, 245
higher HbA1c values were associated with greater BMI, and fewer minutes of physical 246 activity per day/week. Higher BMI values also depicted older age, doctor-diagnosed HBP, 247 having ever had diabetes, and fewer minutes of physical activity. Gender differences are also 248 noteworthy: overall, females had lower blood pressure, and lower levels of light (i.e., 249 walking), moderate-, and vigorous-intensity physical activity per day, and during the past 7 250
days. 251
Hypothesis testing was performed using a bootstrapping SPSS dialogue (Hayes, 2013, 252 Hayes, 2009). Bootstrapping was performed separately for each of the following age-related 253 subgroups: aged up to 39; over 40; over 50; and over 60. In each bootstrapping model HbA1c 254 (mmol/mol) was entered as the outcome ('Variable Y'), while PCP status was treated as the 255 predictor ('Variable X'). BMI and the six IPAQ/physical activity levels, were treated as 256 mediator variables ('Variables M'). Diabetes status (whether participants had ever had 257 diabetes), blood pressure (doctor-diagnosed), and gender, were treated as control variables 258 (i.e., covariates). The conservative Sobel test was used to determine mediation. Results are 259 shown in Tables 3 and 4 . 260 0 to 39 years. PCP status directly predicted glycaemic control, such that people who 261 had agreed a PCP had higher HbA1c values compared to those without a PCP. Neither BMI 262 nor physical activity mediated this relationship. 263
Over 40 years. PCP status directly predicted HbA1c; patients with a PCP tended to 264 have poorer glycaemic control. This relationship was mediated by BMI, whereby patients 265 who had a care plan had both higher BMI and higher HbA1c values, compared to those 266 without a plan. This depicted a mediator effect because greater BMI was also associated with 267 higher HbA1c levels (see Figure 1) . This indirect effect was significant based on the 268 conservative Sobel test (z = 2.15, p <0.05), and accounted for 13.1% of the total effect ofPCP status on HbA1c. Controlling for diabetes status and other covariates attenuated the 270 indirect effect (Sobel test p > 0.05), but did not completely abolish it (see Table 3 ). 271
Over 50 years. Having a PCP was associated with higher HbA1c levels in this group. 272
This association was mediated by BMI, whereby those with a care plan had higher BMI, and 273 poorer glycaemic control, compared to people without a PCP (see Figure 2) . The Sobel test 274 for this indirect effect was significant (z = 2.06, p <0.05). The mediator effect accounted for 275 18.2% of the total effect of PCP status on HbA1c. Adjusting for covariates weakened but did 276 not entirely negate the indirect effect (Table 3) . Contrary to what was hypothesised patients with a PCP had higher HbA1c levels. However, 287
higher BMI scores partly explained this relationship (see Figures 1 and 2) . Previous research 288 has implicated BMI in elevated HbA1c (Power and Thomas, 2011, Senechal et al., 2013, 289 Patiakas and Charalampous, 2010). Interestingly, there was no evidence implicating physical 290 activity in PCP -HbA1c relations, despite previous studies associating exercise with 291 glycaemic control (Umpierre et al., 2011 , Gay et al., 2016 , Hamer et al., 2014 . 292
Previous research has implicated PCPs in lower HbA1c (Coulter et al., 2015) . An obvious 293 explanation for the higher HbA1c levels observed here is the mediating effect of BMI. It ispossible PCPs may lead to elevated HbA1c values, if patients are gaining weight, perhaps due 295 to noncompliance with PCP targets or action plans, and/or other factors, such poor doctor-296 patient interaction (Paternotte et al., 2015) . Previous research shows a strong connection 297 between higher BMI scores and higher HbA1c, with one study linking elevated BMI scores in 298 childhood to a 23.9-fold increased risk of a HbA1c ≥ 7% later in life (Power and Thomas, 299 2011). Thus, patients with high HbA1c/BMI stand to benefit considerably from information 300 prescriptions (Diabetes UK, 2015a) and other forms of personalised care (Coulter et al., 301 2013) that specifically target weight control. The fact that BMI mediated the PCP -HbA1c 302 relationship specifically in 40 to 60 year olds suggests BMI plays a particularly important 303 role in personalised care and glycaemic control in middle-aged patients (Owen et al., 2015) . 304
Another possible explanation for the higher HbA1c levels in patients with PCPs is that 305 care plans tend to be offered to patients with poorer glycaemic control (Diabetes UK, 2015a). 306
Offering PCPs to people with higher HbA1c reflects current recommendations that 307 information prescriptions should target individuals at high risk of complications (i.e., high 308 HbA1c) (Diabetes UK, 2017). The mediating effect of BMI may simply reflect the fact that 309 patients with high HbA1c also tend to have high BMI scores (Power and Thomas, 2011), 310 and/or that GPs are simply more likely to offer PCPs to patients exhibiting both risk factors 311
(Diabetes UK, 2009). 312
The fact that physical activity did not affect relations between PCPs and HbA1c is 313 worrying given that inactivity significantly increases the risk of complications (Waden et al., 314 2008 , Blomster et al., 2013 . Evidence from a long-term prospective study associates 315 moderate-to-vigorous levels of activity with a reduced risk of cardiovascular problems, 316 microvascular complications, and premature mortality (Blomster et al., 2013) . Although other 317 research suggests no link between exercise and complications (Makura et al., 2013) , theinactivity should be an important factor in personalised care planning and glycaemic control. 320
This seems particularly relevant to middle-aged/older patients. This demographic may find 321 moderate-to-vigorous intensity exercises (e.g., fast cycling, running) particularly challenging, 322 especially if conducted on a regular basis (Sparling et al., 2015) , negating the glycaemic 323 benefits (Kennedy et al., 2013) . Other factors, such as increased calorie intake, or variations 324 in insulin dosage, may also attenuate the effect of physical activity on HbA1c, and should be 325 carefully explored by doctors and patients when setting up PCPs (Kennedy et al., 2013) . 326
This study has some limitations. Firstly, while BMI mediated the PCP -HbA1c 327 association, BMI is a poor index of body fat, or morbidity and mortality risk (Nuttall, 2015) . 328
Another problem is that data analysis did not control for every covariate relevant to PCP 329 status, BMI, and HbA1c (e.g., dietary intake, or insulin resistance). Additionally, there is 330 uncertainty regarding the actual content of PCPs agreed with patients in this data set; due to 331 the personalised nature of PCPs, the HSE does include individual HbA1c targets, or 332 recommended lifestyle changes. Furthermore, the HSE data analysed here pre-dates the 333 launch of information prescriptions by Diabetes UK (Diabetes UK, 2015b). As this new 334 personalised care tool is IT-based and can be deployed in a matter of minutes (Diabetes UK, 335 2017), it's impact on glycaemic control may be more dramatic than more generic PCP 336 formats (Coulter et al., 2013) . Finally, the cross-sectional nature of the design precludes 337 inferences about the possible direction of causality. 338 This is the first study to examine how BMI and physical activity influence relations 339 between personalised care planning and glycaemic control (Diabetes UK, 2017). The study 340 suggests BMI partly explains higher HbA1c levels in patients with a PCP. The irrelevance of 341 physical activity in this context is worrying given recent population-based prospective 342 evidence implicating exercise intensity in diabetes complications (Blomster et al., 2013) . 
